Baldwin Wealth Partners LLC MA Grows Stock Holdings in Danaher Corporation $DHR

Key Points

• Baldwin Wealth Partners LLC MA increased its holdings in Danaher Corporation by 3.0%, now owning 82,504 shares valued at approximately $16.3 million, making Danaher its 26th largest holding.
• Danaher Corporation reported quarterly earnings of $1.80 per share, surpassing estimates and has projected FY 2025 EPS guidance between $7.700 and $7.800.
• The company announced a quarterly dividend of $0.32 per share, with a payout ratio of 27.23%, and a yield of 0.6%, payable on October 31st.

Baldwin Wealth Partners LLC MA grew its holdings in Danaher Corporation (NYSE:DHR - Free Report) by 3.0% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 82,504 shares of the conglomerate's stock after purchasing an additional 2,424 shares during the quarter. Danaher comprises approximately 1.1% of Baldwin Wealth Partners LLC MA's portfolio, making the stock its 26th largest holding. Baldwin Wealth Partners LLC MA's holdings in Danaher were worth $16,298,000 as of its most recent SEC filing.

A number of other institutional investors have also bought and sold shares of DHR. MGO One Seven LLC raised its position in shares of Danaher by 485.7% during the 1st quarter. MGO One Seven LLC now owns 25,098 shares of the conglomerate's stock valued at $5,145,000 after buying an additional 20,813 shares during the period. Chicago Capital LLC grew its stake in shares of Danaher by 11.6% in the second quarter. Chicago Capital LLC now owns 13,332 shares of the conglomerate's stock worth $2,634,000 after acquiring an additional 1,391 shares in the last quarter. UniSuper Management Pty Ltd grew its stake in shares of Danaher by 1.6% in the first quarter. UniSuper Management Pty Ltd now owns 170,505 shares of the conglomerate's stock worth $34,954,000 after acquiring an additional 2,667 shares in the last quarter. Asahi Life Asset Management CO. LTD. purchased a new stake in shares of Danaher during the 1st quarter worth $539,000. Finally, Horizon Financial Services LLC lifted its position in shares of Danaher by 20,400.0% during the 1st quarter. Horizon Financial Services LLC now owns 8,200 shares of the conglomerate's stock worth $1,681,000 after purchasing an additional 8,160 shares during the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Price Performance

DHR opened at $204.31 on Friday. The company has a 50-day moving average of $200.55 and a 200-day moving average of $197.32. The company has a market capitalization of $146.29 billion, a P/E ratio of 43.47, a PEG ratio of 2.92 and a beta of 0.77. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $279.41. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62.

Danaher (NYSE:DHR - Get Free Report) last posted its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, beating the consensus estimate of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The business had revenue of $5.94 billion during the quarter, compared to analyst estimates of $5.83 billion. During the same period in the previous year, the business posted $1.72 EPS. The company's quarterly revenue was up 3.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. Equities analysts expect that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be paid a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date of this dividend is Friday, September 26th. Danaher's payout ratio is presently 27.23%.

Insider Activity at Danaher

In other Danaher news, Director Teri List sold 2,778 shares of the business's stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the sale, the director directly owned 20,751 shares in the company, valued at approximately $4,379,706.06. The trade was a 11.81% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 11.10% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the stock. Scotiabank raised shares of Danaher from a "sector perform" rating to a "sector outperform" rating and set a $275.00 price target for the company in a research report on Friday, July 11th. UBS Group lowered their target price on shares of Danaher from $240.00 to $225.00 and set a "buy" rating on the stock in a research report on Wednesday, July 23rd. Wall Street Zen upgraded shares of Danaher from a "hold" rating to a "buy" rating in a research report on Friday, June 27th. Robert W. Baird raised their target price on shares of Danaher from $225.00 to $226.00 and gave the stock an "outperform" rating in a research report on Friday, July 18th. Finally, Redburn Partners set a $220.00 price target on shares of Danaher in a research note on Wednesday. Seventeen investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the company's stock. According to data from MarketBeat, Danaher currently has an average rating of "Moderate Buy" and an average target price of $244.60.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.